Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
27.92%Interest Expense Margin
VS
Market
Sector
Industry
History
$ 2.86Close
$ 1.42 - $ 24.24 52-Week Range
Ticker Information
Ticker
XFORCompany Name
X4 PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQX4 PHARMACEUTICALS INC - Interest Expense Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
XFOR - Int. Exp. % Historical data
| Date | Interest Expense | Interest Expense Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 9.15M | 27.92% | $ 32.77M |
| 3/31/2025 | $ 9.1M | 29% | $ 31.36M |
| 12/31/2024 | $ 8.77M | 342.9% | $ 2.56M |
| 9/30/2024 | $ 8.35M | 743.54% | $ 1.12M |
| 6/30/2024 | $ 7.57M | 1344.58% | $ 563K |
| 3/31/2024 | $ 6.54M | 0% | $ 0 |
| 12/31/2023 | $ 5.78M | 0% | $ 0 |
| 9/30/2023 | $ 5.04M | 0% | $ 0 |
| 6/30/2023 | $ 4.42M | 0% | $ 0 |
| 3/31/2023 | $ 4.19M | 0% | $ 0 |
Key Performance Insights, Last 5 Years
- X4 PHARMACEUTICALS INC's latest trailing twelve months (TTM) Int. Exp. % stands at 83.87%.
- Over the past 5 years, X4 PHARMACEUTICALS INC's average Int. Exp. % has been 380.2%.
- The median Int. Exp. % for X4 PHARMACEUTICALS INC during this period was 89.6%
- X4 PHARMACEUTICALS INC reached its highest Int. Exp. % over the past 5 years at 1344.58%.
- The lowest Int. Exp. % recorded by X4 PHARMACEUTICALS INC in the same timeframe 27.92%
X4 PHARMACEUTICALS INC's Int. Exp. % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Int. Exp. % Benchmarks
Similar metrics to Revenues:
- Interest Expense - [Income Statement] Interest expense is the cost incurred by a business for borrowing funds.
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation and Amortization Margin - [Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].
Definition of Interest Expense Margin
[Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].Int. Exp. / Revenues
(=) Int. Exp. % Int. Exp. % for X4 PHARMACEUTICALS INC is calculated as follows: Int. Exp. [ $ 2.52M ] / Revenues [ $ 3M ]
(=) Int. Exp. % [ 83.87% ] XFOR - Interest Expense Margin, Last 5 years
27.92%
Minimum
Jun 30, 2025
1344.58%
Maximum
Jun 30, 2024
380.2%
Average
89.6%
Median
Int. Exp. % Benchmark AnalysisMarket
The chart above depicts the distribution of Int. Exp. % for companies in the Total Stock Market. The average Int. Exp. % of the companies is 1.63% with a standard deviation of 2.2%.
The following table provides additional summary stats:
Int. Exp. % in the Market:
| filtered constituents | 3.15K |
|---|---|
| min | -4.94% |
| max | 8.49% |
| average | 1.63% |
| median | 0.79% |
| std | 2.2% |